Open access · CC-BY
via OpenAlex
Mesenchymal stem cells for treatment of aortic aneurysms
Aika Yamawaki-Ogata, Ryotaro Hashizume, Xianming Fu, Akihiko Usui, Yuji Narita
World Journal of Stem Cells · 2014 · ▲ 33 citations
Abstract
An aortic aneurysm (AA) is a silent but life-threatening disease that involves rupture. It occurs mainly in aging and severe atherosclerotic damage of the aortic wall. Even though surgical intervention is effective to prevent rupture, surgery for the thoracic and thoraco-abdominal aorta is an invasive procedure with high mortality and morbidity. Therefore, an alternative strategy for treatment of AA is required. Recently, the molecular pathology of AA has been clarified. AA is caused by an imbalance between the synthesis and degradation of extracellular matrices in the aortic wall. Chronic inflammation enhances the degradation of matrices directly and indirectly, making control of the chronic inflammation crucial for aneurysmal development. Meanwhile, mesenchymal stem cells (MSCs) are known to be obtained from an adult population and to differentiate into various types of cells. In addition, MSCs have not only the potential anti-inflammatory and immunosuppressive properties but also can be recruited into damaged tissue. MSCs have been widely used as a source for cell therapy to treat various diseases involving graft-versus-host disease, stroke, myocardial infarction, and chronic inflammatory disease such as Crohn's disease clinically. Therefore, administration of MSCs might be available to treat AA using anti-inflammatory and immnosuppressive properties. This review provides a summary of several studies on "Cell Therapy for Aortic Aneurysm" including our recent data, and we also discuss the possibility of this kind of treatment.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.4252/wjsc.v6.i3.278
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Yamawaki-Ogata, A., Hashizume, R., Fu, X., Usui, A., & Narita, Y. (2014). Mesenchymal stem cells for treatment of aortic aneurysms. <em>World Journal of Stem Cells</em>. https://doi.org/10.4252/wjsc.v6.i3.278
Vancouver
Yamawaki-Ogata A, Hashizume R, Fu X, Usui A, Narita Y. Mesenchymal stem cells for treatment of aortic aneurysms. World Journal of Stem Cells. 2014. doi:10.4252/wjsc.v6.i3.278.
BibTeX
@article{aika2014Mesenc,
title = {Mesenchymal stem cells for treatment of aortic aneurysms},
author = {Aika Yamawaki-Ogata and Ryotaro Hashizume and Xianming Fu and Akihiko Usui and Yuji Narita},
journal = {World Journal of Stem Cells},
year = {2014},
doi = {10.4252/wjsc.v6.i3.278},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Stem Cells and Cloning Advances and Applications 2015
Open access · CC-BY
Mesenchymal stem cell therapy for osteoarthritis: current perspectives
PubMed Central 2019
Preprint · CC-BY
Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases.
BioMed Research International 2011
Open access · CC-BY
Mesenchymal Stem Cell‐Based Tissue Engineering for Chondrogenesis
Current Molecular Biology Reports 2020
Preprint · OA
Senescent Mesenchymal Stem Cells: Disease Mechanism and Treatment Strategy
Frontiers in Immunology 2022
Open access · CC-BY
Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy
Stem Cell Research & Therapy 2025
Open access · CC-BY